This is an NIH research grant for early-stage drug and biologic discovery — identifying and validating therapeutic candidates for heart, lung, blood, and sleep diseases — with no clinical trials allowed. It fits small biotech and life-science research organizations; retail, finance, housing, and any business outside therapeutic R&D should not bother applying. The award amount is not published.
- Best for
- Small biotech and life-science companies working on heart, lung, blood, or sleep therapies, Universities and academic research teams doing early-stage translational research, Nonprofits with drug or biologic discovery programs, Tribal, state, or local government research entities
- Not for
- Businesses outside healthcare, biotech, or life-science research, Projects that need clinical trials — this program does not allow them, Organizations seeking general operating or commercialization funding rather than early-stage R&D
These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.